Echo45 Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$356K Sell
1,403
-164
-10% -$38.2K 0.18% 52
2026
Q1
$383K Buy
+1,567
New +$365K 0.22% 48
2023
Q1
Sell
-1,653
Closed -$292K 58
2022
Q4
$292K Buy
1,653
+212
+15% +$36.6K 0.26% 35
2022
Q3
$235K Sell
1,441
-479
-25% -$81.1K 0.24% 33
2022
Q2
$341K Sell
1,920
-824
-30% -$147K 0.32% 28
2022
Q1
$486K Sell
2,744
-495
-15% -$84.2K 0.38% 34
2021
Q4
$554K Buy
+3,239
New +$530K 0.44% 39

Other funds holding JNJ

Echo45 Advisors's JNJ Position: Q2 2026 in Review

Echo45 Advisors reduced its Johnson & Johnson (JNJ) stake by 10% in Q2 2026, selling an estimated $38.2K and leaving 1,403 shares worth $356K. The position accounts for 0.18% of the portfolio, ranked #52.

Echo45 Advisors first reported a position in JNJ in Q4 2021 and has held it in 7 quarters since. The position peaked at $554K in Q4 2021. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Echo45 Advisors held 1,403 shares of Johnson & Johnson worth $356K as of Q2 2026.
  • Echo45 Advisors sold 164 Johnson & Johnson shares in Q2 2026, an estimated $38.2K.
  • Johnson & Johnson made up 0.18% of Echo45 Advisors's portfolio in Q2 2026, its #52 holding.
  • Echo45 Advisors first reported a position in Johnson & Johnson in Q4 2021 and has held it in 7 quarters since.
  • Echo45 Advisors's Johnson & Johnson position peaked at $554K in Q4 2021.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Echo45 Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.